Harbour BioMed Announces IND Clearance for HBM9027 in the U.S.
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 24, 2024 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) announced that the Company has been granted the clearance of Investigational New Drug (IND) from the Food and Drug...
Infosys Brings AI-First Technologies to Centre Court for a More Immersive Australian Open 2024 Experience
Infosys and Tennis Australia launch digital platforms to empower fan, player, and media with all-new generative AI features Infosys also launched an all-new Gen AI experience 'Rafa Forever' inviting millions of fans missing Rafa at AO to celebrate...
Matrixport's Cactus Custody™ Enhance Offerings with Advanced Digital Asset Auditing Features with Elven Partnership
Strategic partnership combines Cactus' robust security infrastructure with Elven's cutting-edge crypto accounting and treasury management expertise SINGAPORE, Jan. 24, 2024 /PRNewswire/ -- Cactus Custody™, Matrixport's qualified institutional...
AXA's Title-Sponsored "The 31st Green Power Hike" Successfully Completed
Promoting the "Leave No Trace" message to create a greener future HONG KONG, Jan. 24, 2024 /PRNewswire/ -- The 31st Green Power Hike, organised by Green Power with AXA as the Title Sponsor for the first time, successfully took place on 13 January....
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs)
SHANGHAI and INCHEON, South Korea, Jan. 24, 2024 /PRNewswire/ -- WuXi XDC(2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market, and Celltrion, Inc....
SUMSEI Triumphs at CES 2024, Solidifying Its Position as a Premier Home Appliance Brand Redefining the Intersection of Nature and Technology
Sensory Engagement: An Immersive Experiential Booth Articulating the Brand Philosophy of 'Nature, Anytime Anywhere' Earning High Acclaim and Positive Reception for 'Air Shower,' a Pioneering Product in a New Category, and 'In the Forest' SEOUL,...
"Home in Shenyang is Great": Shenyang, China, is building a high-standard public service system for foreigners
SHENYANG, China, Jan. 24, 2024 /PRNewswire/ -- A news report from CRI Online: "Shenyang is now more internationalized, with the construction of international hospitals, international schools and better infrastructure. Both foreigners and local...
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors
Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 monotherapy and combination therapy with KEYTRUDA® The clinical trial aims to enroll a total of 67 patients across four institutions in Australia...